Polyamine- and NADPH-dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise

Free Radical Biology and Medicine

Volumn 105, Issue , 2017, Pages 16-27

  Gobert, Alain P ^a,c   Wilson, Keith T ^a,b,c,d,e  

^a Hepatology and Nutrition   (United States)

^b and Immunology ^*  (United States)

^c Center for Mucosal Inflammation and Cancer   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; NADPH oxidase; Polyamines; Reactive oxygen species

Indexed keywords

ARGINASE; ARGININE; BACTERIAL PROTEIN; CAGA PROTEIN; CATALASE; FLAVOPROTEIN; HYDROGEN PEROXIDE; ORNITHINE DECARBOXYLASE; OXIDOREDUCTASE; OXYGEN; PEROXIREDOXIN; POLYAMINE; PROTEIN DUOX2; PROTEIN MDAB; PROTEIN NAPA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SPERMIDINE; SPERMINE; SPERMINE OXIDASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

APOPTOSIS; BACTERIAL SURVIVAL; BIOAVAILABILITY; CARCINOGENESIS; DNA DAMAGE; ECOLOGICAL NICHE; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENICITY; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STOMACH DISEASE; ANIMAL; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; DNA DAMAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; NADP; NADPH OXIDASES; OXIDATIVE STRESS; POLYAMINES; REACTIVE OXYGEN SPECIES;

EID: 85008640889     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.09.024     Document Type: Review

References (131)

1. [1] Blaser, M.J., Chen, Y., Reibman, J., Does Helicobacter pylori protect against asthma and allergy?. Gut 57 (2008), 561–567.
2. [2] Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., Schlemper, R.J., Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345 (2001), 784–789.
3. [3] Vohlonen, I., Pukkala, E., Malila, N., Harkonen, M., Hakama, M., Koistinen, V., Sipponen, P., Risk of gastric cancer in Helicobacter pylori infection in a 15-year follow-up. Scand. J. Gastroenterol. 51 (2016), 1159–1164.
4. [4] Malfertheiner, P., Megraud, F., O'Morain, C.A., Atherton, J., Axon, A.T., Bazzoli, F., Gensini, G.F., Gisbert, J.P., Graham, D.Y., Rokkas, T., El-Omar, E.M., Kuipers, E.J., European Helicobacter Study Group, Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut 61 (2012), 646–664.
5. [5] Marcus, E.A., Sachs, G., Scott, D.R., Eradication of Helicobacter pylori infection. Curr. Gastroenterol. Rep., 18, 2016, 33.
6. [6] Morgan, D.R., Torres, J., Sexton, R., Herrero, R., Salazar-Martinez, E., Greenberg, E.R., Bravo, L.E., Dominguez, R.L., Ferreccio, C., Lazcano-Ponce, E.C., Meza-Montenegro, M.M., Pena, E.M., Pena, R., Correa, P., Martinez, M.E., Chey, W.D., Valdivieso, M., Anderson, G.L., Goodman, G.E., Crowley, J.J., Baker, L.H., Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA 309 (2013), 578–586.
7. [7] Ford, A.C., Forman, D., Hunt, R.H., Yuan, Y., Moayyedi, P., Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ, 348, 2014, g3174.
8. [8] Mueller, D., Tegtmeyer, N., Brandt, S., Yamaoka, Y., De Poire, E., Sgouras, D., Wessler, S., Torres, J., Smolka, A., Backert, S., c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J. Clin. Investig. 122 (2012), 1553–1566.
9. [9] Naito, M., Yamazaki, T., Tsutsumi, R., Higashi, H., Onoe, K., Yamazaki, S., Azuma, T., Hatakeyama, M., Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130 (2006), 1181–1190.
10. [10] Duncan, S.S., Valk, P.L., Shaffer, C.L., Bordenstein, S.R., Cover, T.L., J-Western forms of Helicobacter pylori cagA constitute a distinct phylogenetic group with a widespread geographic distribution. J. Bacteriol. 194 (2012), 1593–1604.
11. [11] Jones, K.R., Joo, Y.M., Jang, S., Yoo, Y.J., Lee, H.S., Chung, I.S., Olsen, C.H., Whitmire, J.M., Merrell, D.S., Cha, J.H., Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J. Clin. Microbiol. 47 (2009), 959–968.
12. [12] Yamaoka, Y., El-Zimaity, H.M., Gutierrez, O., Figura, N., Kim, J.G., Kodama, T., Kashima, K., Graham, D.Y., Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117 (1999), 342–349.
13. [13] Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., Hatakeyama, M., SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295 (2002), 683–686.
14. [14] Backert, S., Moese, S., Selbach, M., Brinkmann, V., Meyer, T.F., Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol. Microbiol. 42 (2001), 631–644.
15. [15] Higashi, H., Nakaya, A., Tsutsumi, R., Yokoyama, K., Fujii, Y., Ishikawa, S., Higuchi, M., Takahashi, A., Kurashima, Y., Teishikata, Y., Tanaka, S., Azuma, T., Hatakeyama, M., Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279 (2004), 17205–17216.
16. [16] Umeda, M., Murata-Kamiya, N., Saito, Y., Ohba, Y., Takahashi, M., Hatakeyama, M., Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability. J. Biol. Chem. 284 (2009), 22166–22172.
17. [17] Segal, E.D., Lange, C., Covacci, A., Tompkins, L.S., Falkow, S., Induction of host signal transduction pathways by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 94 (1997), 7595–7599.
18. [18] Suzuki, M., Mimuro, H., Kiga, K., Fukumatsu, M., Ishijima, N., Morikawa, H., Nagai, S., Koyasu, S., Gilman, R.H., Kersulyte, D., Berg, D.E., Sasakawa, C., Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 5 (2009), 23–34.
19. [19] Gobert, A.P., Verriere, T., de Sablet, T., Peek, R.M. Jr., Chaturvedi, R., Wilson, K.T., Haem oxygenase-1 inhibits phosphorylation of the Helicobacter pylori oncoprotein CagA in gastric epithelial cells. Cell. Microbiol. 15 (2013), 145–156.
20. [20] Blaser, M.J., Perez-Perez, G.I., Kleanthous, H., Cover, T.L., Peek, R.M., Chyou, P.H., Stemmermann, G.N., Nomura, A., Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55 (1995), 2111–2115.
21. [21] Supajatura, V., Ushio, H., Wada, A., Yahiro, K., Okumura, K., Ogawa, H., Hirayama, T., Ra, C., Cutting edge: vaca, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J. Immunol. 168 (2002), 2603–2607.
22. [22] Raju, D., Hussey, S., Ang, M., Terebiznik, M.R., Sibony, M., Galindo-Mata, E., Gupta, V., Blanke, S.R., Delgado, A., Romero-Gallo, J., Ramjeet, M.S., Mascarenhas, H., Peek, R.M., Correa, P., Streutker, C., Hold, G., Kunstmann, E., Yoshimori, T., Silverberg, M.S., Girardin, S.E., Philpott, D.J., El Omar, E., Jones, N.L., Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 142 (2012), 1160–1171.
23. [23] Atherton, J.C., Peek, R.M. Jr., Tham, K.T., Cover, T.L., Blaser, M.J., Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112 (1997), 92–99.
24. [24] Noto, J.M., Gaddy, J.A., Lee, J.Y., Piazuelo, M.B., Friedman, D.B., Colvin, D.C., Romero-Gallo, J., Suarez, G., Loh, J., Slaughter, J.C., Tan, S., Morgan, D.R., Wilson, K.T., Bravo, L.E., Correa, P., Cover, T.L., Amieva, M.R., Peek, R.M. Jr., Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J. Clin. Investig. 123 (2013), 479–492.
25. [25] Fox, J.G., Rogers, A.B., Ihrig, M., Taylor, N.S., Whary, M.T., Dockray, G., Varro, A., Wang, T.C., Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res. 63 (2003), 942–950.
26. [26] Correa, P., A human model of gastric carcinogenesis. Cancer Res. 48 (1988), 3554–3560.
27. [27] Chaturvedi, R., Asim, M., Hoge, S., Lewis, N.D., Singh, K., Barry, D.P., de Sablet, T., Piazuelo, M.B., Sarvaria, A.R., Cheng, Y., Closs, E.I., Casero, R.A. Jr., Gobert, A.P., Wilson, K.T., Polyamines impair immunity to Helicobacter pylori by inhibiting L-Arginine uptake required for nitric oxide production. Gastroenterology 139 (2010), 1686–1698.
28. [28] Yeramian, A., Martin, L., Serrat, N., Arpa, L., Soler, C., Bertran, J., McLeod, C., Palacin, M., Modolell, M., Lloberas, J., Celada, A., Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages. J. Immunol. 176 (2006), 5918–5924.
29. [29] Barry, D.P., Asim, M., Scull, B.P., Piazuelo, M.B., de Sablet, T., Lewis, N.D., Coburn, L.A., Singh, K., Ellies, L.G., Gobert, A.P., Chaturvedi, R., Wilson, K.T., Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. Plos One, 6, 2011, e29046.
30. [30] Gobert, A.P., Verriere, T., Asim, M., Barry, D.P., Piazuelo, M.B., de Sablet, T., Delgado, A.G., Bravo, L.E., Correa, P., Peek, R.M. Jr., Chaturvedi, R., Wilson, K.T., Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori. J. Immunol. 193 (2014), 3013–3022.
31. [31] Gobert, A.P., Cheng, Y., Wang, J.Y., Boucher, J.L., Iyer, R.K., Cederbaum, S.D., Casero, R.A. Jr., Newton, J.C., Wilson, K.T., Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J. Immunol. 168 (2002), 4692–4700.
32. [32] Lewis, N.D., Asim, M., Barry, D.P., Singh, K., de Sablet, T., Boucher, J.L., Gobert, A.P., Chaturvedi, R., Wilson, K.T., Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J. Immunol. 184 (2010), 2572–2582.
33. [33] Lewis, N.D., Asim, M., Barry, D.P., de Sablet, T., Singh, K., Piazuelo, M.B., Gobert, A.P., Chaturvedi, R., Wilson, K.T., Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II. J. Immunol. 186 (2011), 3632–3641.
34. [34] D.M. Hardbower, M. Asim, T. Murray-Stewart, R.A. Casero, Jr., T. Verriere, N.D. Lewis, R. Chaturvedi, M.B. Piazuelo, K.T. Wilson, Arginase 2 deletion leads to enhanced M1 macrophage activation and upregulated polyamine metabolism in response to Helicobacter pylori infection, Amino Acids, 2016.
35. [35] Gobert, A.P., Wilson, K.T., The immune battle against Helicobacter pylori infection: no offense. Trends Microbiol 24 (2016), 366–376.
36. [36] Konturek, P.C., Rembiasz, K., Konturek, S.J., Stachura, J., Bielanski, W., Galuschka, K., Karcz, D., Hahn, E.G., Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig. Dis. Sci. 48 (2003), 36–46.
37. [37] Patchett, S.E., Alstead, E.M., Butruk, L., Przytulski, K., Farthing, M.J., Ornithine decarboxylase as a marker for premalignancy in the stomach. Gut 37 (1995), 13–16.
38. [38] Linsalata, M., Russo, F., Notarnicola, M., Berloco, P., Di Leo, A., Polyamine profile in human gastric mucosa infected by Helicobacter pylori. Ital. J. Gastroenterol. Hepatol. 30 (1998), 484–489.
39. [39] Elitsur, Y., Majumdar, A.P., Tureaud, J., Dosescu, J., Neace, C., Velusamy, L., Moshier, J.A., Tyrosine kinase and ornithine decarboxylase activation in children with Helicobacter pylori gastritis. Life Sci. 65 (1999), 1373–1380.
40. [40] Patchett, S.E., Katelaris, P.H., Zhang, Z.W., Alstead, E.M., Domizio, P., Farthing, M.J., Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection. Gut 39 (1996), 807–810.
41. [41] Alam, K., Arlow, F.L., Ma, C.K., Schubert, T.T., Decrease in ornithine decarboxylase activity after eradication of Helicobacter pylori. Am. J. Gastroenterol. 89 (1994), 888–893.
42. [42] Hirasawa, R., Tatsuta, M., Iishi, H., Yano, H., Baba, M., Uedo, N., Sakai, N., Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori. Am. J. Gastroenterol. 94 (1999), 2398–2402.
43. [43] Messa, C., Di Leo, A., Greco, B., Caradonna, L., Amati, L., Linsalata, M., Giorgio, I., Jirillo, E., Successful eradicating treatment of Helicobacter pylori in patients with chronic gastritis: gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy. Immunopharmacol. Immunotoxicol. 18 (1996), 1–13.
44. [44] Xu, X., Liu, Z., Fang, M., Yu, H., Liang, X., Li, X., Liu, X., Chen, C., Jia, J., Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: implication for progression of gastric diseases. Exp. Biol. Med. 237 (2012), 435–441.
45. [45] Cheng, Y., Chaturvedi, R., Asim, M., Bussiere, F.I., Scholz, A., Xu, H., Casero, R.A. Jr., Wilson, K.T., Helicobacter pylori-induced macrophage apoptosis requires activation of ornithine decarboxylase by c-Myc. J. Biol. Chem. 280 (2005), 22492–22496.
46. [46] Asim, M., Chaturvedi, R., Hoge, S., Lewis, N.D., Singh, K., Barry, D.P., Algood, H.S., de Sablet, T., Gobert, A.P., Wilson, K.T., Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos.c-Jun activator protein-1 complex that causes apoptosis in macrophages. J. Biol. Chem. 285 (2010), 20343–20357.
47. [47] Chaturvedi, R., Cheng, Y., Asim, M., Bussiere, F.I., Xu, H., Gobert, A.P., Hacker, A., Casero, R.A. Jr., Wilson, K.T., Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J. Biol. Chem. 279 (2004), 40161–40173.
48. [48] Wang, Y., Devereux, W., Woster, P.M., Stewart, T.M., Hacker, A., Casero, R.A. Jr., Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res. 61 (2001), 5370–5373.
49. [49] Xu, H., Chaturvedi, R., Cheng, Y., Bussiere, F.I., Asim, M., Yao, M.D., Potosky, D., Meltzer, S.J., Rhee, J.G., Kim, S.S., Moss, S.F., Hacker, A., Wang, Y., Casero, R.A. Jr., Wilson, K.T., Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 64 (2004), 8521–8525.
50. [50] Chaturvedi, R., Asim, M., Romero-Gallo, J., Barry, D.P., Hoge, S., de Sablet, T., Delgado, A.G., Wroblewski, L.E., Piazuelo, M.B., Yan, F., Israel, D.A., Casero, R.A. Jr., Correa, P., Gobert, A.P., Polk, D.B., Peek, R.M. Jr., Wilson, K.T., Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 141 (2011), 1696–1708.
51. [51] Chaturvedi, R., de Sablet, T., Asim, M., Piazuelo, M.B., Barry, D.P., Verriere, T.G., Sierra, J.C., Hardbower, D.M., Delgado, A.G., Schneider, B.G., Israel, D.A., Romero-Gallo, J., Nagy, T.A., Morgan, D.R., Murray-Stewart, T., Bravo, L.E., Peek, R.M. Jr., Fox, J.G., Woster, P.M., Casero, R.A. Jr., Correa, P., Wilson, K.T., Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase. Oncogene 34 (2015), 3429–3440.
52. [52] Banfi, B., Clark, R.A., Steger, K., Krause, K.H., Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278 (2003), 3510–3513.
53. [53] Teshima, S., Kutsumi, H., Kawahara, T., Kishi, K., Rokutan, K., Regulation of growth and apoptosis of cultured guinea pig gastric mucosal cells by mitogenic oxidase 1. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000), G1169–G1176.
54. [54] Salles, N., Szanto, I., Herrmann, F., Armenian, B., Stumm, M., Stauffer, E., Michel, J.P., Krause, K.H., Expression of mRNA for ROS-generating NADPH oxidases in the aging stomach. Exp. Gerontol. 40 (2005), 005353–005357.
55. [55] Tominaga, K., Kawahara, T., Sano, T., Toida, K., Kuwano, Y., Sasaki, H., Kawai, T., Teshima-Kondo, S., Rokutan, K., Evidence for cancer-associated expression of NADPH oxidase 1 (Nox1)-based oxidase system in the human stomach. Free Radic. Biol. Med. 43 (2007), 1627–1638.
56. [56] den Hartog, G., Chattopadhyay, R., Ablack, A., Hall, E.H., Butcher, L.D., Bhattacharyya, A., Eckmann, L., Harris, P.R., Das, S., Ernst, P.B., Crowe, S.E., Regulation of Rac1 and reactive oxygen species production in response to infection of gastrointestinal epithelia. PLoS Pathog., 12, 2016, e1005382.
57. [57] Yoshida, L.S., Nishida, S., Shimoyama, T., Kawahara, T., Kondo-Teshima, S., Rokutan, K., Kobayashi, T., Tsunawaki, S., Superoxide generation by Nox1 in guinea pig gastric mucosal cells involves a component with p67(phox)-ability. Biol. Pharm. Bull. 27 (2004), 147–155.
58. [58] Kawahara, T., Kohjima, M., Kuwano, Y., Mino, H., Teshima-Kondo, S., Takeya, R., Tsunawaki, S., Wada, A., Sumimoto, H., Rokutan, K., Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am. J. Physiol. Cell Physiol. 288 (2005), C450–C457.
59. [59] Kwok, T., Zabler, D., Urman, S., Rohde, M., Hartig, R., Wessler, S., Misselwitz, R., Berger, J., Sewald, N., Konig, W., Backert, S., Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449 (2007), 862–866.
60. [60] Bauer, G., Bereswill, S., Aichele, P., Glocker, E., Helicobacter pylori protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosis. Carcinogenesis 35 (2014), 1582–1591.
61. [61] Nielsen, H., Andersen, L.P., Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 103 (1992), 1747–1753.
62. [62] Nielsen, H., Birkholz, S., Andersen, L.P., Moran, A.P., Neutrophil activation by Helicobacter pylori lipopolysaccharides. J. Infect. Dis. 170 (1994), 135–139.
63. [63] Allen, L.A., Beecher, B.R., Lynch, J.T., Rohner, O.V., Wittine, L.M., Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J. Immunol. 174 (2005), 3658–3667.
64. [64] Evans, D.J. Jr., Evans, D.G., Takemura, T., Nakano, H., Lampert, H.C., Graham, D.Y., Granger, D.N., Kvietys, P.R., Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63 (1995), 2213–2220.
65. [65] Tonello, F., Dundon, W.G., Satin, B., Molinari, M., Tognon, G., Grandi, G., Del Giudice, G., Rappuoli, R., Montecucco, C., The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol. Microbiol. 34 (1999), 238–246.
66. [66] Satin, B., Del Giudice, G., Bianca, V. Della, Dusi, S., Laudanna, C., Tonello, F., Kelleher, D., Rappuoli, R., Montecucco, C., Rossi, F., The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 191 (2000), 1467–1476.
67. [67] Wang, G., Hong, Y., Olczak, A., Maier, S.E., Maier, R.J., Dual Roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect. Immun. 74 (2006), 6839–6846.
68. [68] Mai, U.E., Perez-Perez, G.I., Wahl, L.M., Wahl, S.M., Blaser, M.J., Smith, P.D., Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J. Clin. Investig. 87 (1991), 894–900.
69. [69] Betten, A., Bylund, J., Christophe, T., Boulay, F., Romero, A., Hellstrand, K., Dahlgren, C., A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J. Clin. Investig. 108 (2001), 1221–1228.
70. 2 in isolated porcine thyroid follicles. Endocrinology 115 (1984), 392–398.
71. 2-generating activity. J. Biol. Chem. 280 (2005), 30046–30054.
72. [72] Hornsby, M.J., Huff, J.L., Kays, R.J., Canfield, D.R., Bevins, C.L., Solnick, J.V., Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology 134 (2008), 1049–1057.
73. [73] Li, H., Zhou, Y., Zheng, Y., Guo, H., Gao, L., Chen, P., Feng, D., Wu, L., Yang, M., Qi, Y., Guo, H., Chang, Y., Chu, F.F., Gao, Q., The gastric mucosa from patients infected with CagA+ or VacA+Helicobacter pylori has a lower level of dual oxidase-2 expression than uninfected or infected with CagA-/VacA- H. pylori. Dig. Dis. Sci. 61 (2016), 2328–2337.
74. [74] Spiegelhalder, C., Gerstenecker, B., Kersten, A., Schiltz, E., Kist, M., Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect. Immun. 61 (1993), 5315–5325.
75. [75] Pesci, E.C., Pickett, C.L., Genetic organization and enzymatic activity of a superoxide dismutase from the microaerophilic human pathogen, Helicobacter pylori. Gene 143 (1994), 111–116.
76. [76] Benov, L.T., Fridovich, I., Escherichia coli expresses a copper- and zinc-containing superoxide dismutase. J. Biol. Chem. 269 (1994), 25310–25314.
77. [77] Seyler, R.W. Jr., Olson, J.W., Maier, R.J., Superoxide dismutase-deficient mutants of Helicobacter pylori are hypersensitive to oxidative stress and defective in host colonization. Infect. Immun. 69 (2001), 4034–4040.
78. [78] Wang, G., Conover, R.C., Olczak, A.A., Alamuri, P., Johnson, M.K., Maier, R.J., Oxidative stress defense mechanisms to counter iron-promoted DNA damage in Helicobacter pylori. Free Radic. Res. 39 (2005), 1183–1191.
79. [79] Morishita, K., Takeuchi, H., Morimoto, N., Shimamura, T., Kadota, Y., Tsuda, M., Taniguchi, T., Ukeda, H., Yamamoto, T., Sugiura, T., Superoxide dismutase activity of Helicobacter pylori per se from 158 clinical isolates and the characteristics. Microbiol Immunol. 56 (2012), 262–272.
80. [80] Hazell, S.L., Evans, D.J. Jr., Graham, D.Y., Helicobacter pylori catalase. J. Gen. Microbiol. 137 (1991), 57–61.
81. [81] Harris, A.G., Hinds, F.E., Beckhouse, A.G., Kolesnikow, T., Hazell, S.L., Resistance to hydrogen peroxide in Helicobacter pylori: role of catalase (KatA) and Fur, and functional analysis of a novel gene product designated ‘KatA-associated protein’, KapA (HP0874). Microbiology 148 (2002), 3813–3825.
82. [82] Wang, G., Conover, R.C., Benoit, S., Olczak, A.A., Olson, J.W., Johnson, M.K., Maier, R.J., Role of a bacterial organic hydroperoxide detoxification system in preventing catalase inactivation. J. Biol. Chem. 279 (2004), 51908–51914.
83. [83] Harris, A.G., Hazell, S.L., Localisation of Helicobacter pylori catalase in both the periplasm and cytoplasm, and its dependence on the twin-arginine target protein, KapA, for activity. FEMS Microbiol. Lett. 229 (2003), 283–289.
84. [84] Benoit, S.L., Maier, R.J., Twin-arginine translocation system in Helicobacter pylori: tatc, but not TatB, is essential for viability. MBio, 5, 2014, e01016-13.
85. [85] Odenbreit, S., Wieland, B., Haas, R., Cloning and genetic characterization of Helicobacter pylori catalase and construction of a catalase-deficient mutant strain. J. Bacteriol. 178 (1996), 6960–6967.
86. [86] Ramarao, N., Gray-Owen, S.D., Meyer, T.F., Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol. Microbiol. 38 (2000), 103–113.
87. [87] Jungblut, P.R., Bumann, D., Haas, G., Zimny-Arndt, U., Holland, P., Lamer, S., Siejak, F., Aebischer, A., Meyer, T.F., Comparative proteome analysis of Helicobacter pylori. Mol. Microbiol. 36 (2000), 710–725.
88. [88] Comtois, S.L., Gidley, M.D., Kelly, D.J., Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori. Microbiol 149 (2003), 121–129.
89. [89] Olczak, A.A., Seyler, R.W. Jr., Olson, J.W., Maier, R.J., Association of Helicobacter pylori antioxidant activities with host colonization proficiency. Infect. Immun. 71 (2003), 580–583.
90. [90] Chuang, M.H., Wu, M.S., Lo, W.L., Lin, J.T., Wong, C.H., Chiou, S.H., The antioxidant protein alkylhydroperoxide reductase of Helicobacter pylori switches from a peroxide reductase to a molecular chaperone function. Proc. Natl. Acad. Sci. USA 103 (2006), 2552–2557.
91. [91] Wang, G., Olczak, A.A., Walton, J.P., Maier, R.J., Contribution of the Helicobacter pylori thiol peroxidase bacterioferritin comigratory protein to oxidative stress resistance and host colonization. Infect. Immun. 73 (2005), 378–384.
92. [92] Lu, J., Holmgren, A., The thioredoxin antioxidant system. Free Radic. Biol. Med. 66 (2014), 75–87.
93. [93] Kuhns, L.G., Wang, G., Maier, R.J., Comparative roles of the two Helicobacter pylori thioredoxins in preventing macromolecule damage. Infect. Immun. 83 (2015), 2935–2943.
94. [94] Baker, L.M., Raudonikiene, A., Hoffman, P.S., Poole, L.B., Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization. J. Bacteriol. 183 (2001), 1961–1973.
95. [95] McGee, D.J., Kumar, S., Viator, R.J., Bolland, J.R., Ruiz, J., Spadafora, D., Testerman, T.L., Kelly, D.J., Pannell, L.K., Windle, H.J., Helicobacter pylori thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses. J. Biol. Chem. 281 (2006), 3290–3296.
96. [96] Olczak, A.A., Olson, J.W., Maier, R.J., Oxidative-stress resistance mutants of Helicobacter pylori. J. Bacteriol. 184 (2002), 3186–3193.
97. [97] Cooksley, C., Jenks, P.J., Green, A., Cockayne, A., Logan, R.P., Hardie, K.R., NapA protects Helicobacter pylori from oxidative stress damage, and its production is influenced by the ferric uptake regulator. J. Med. Microbiol. 52 (2003), 461–469.
98. [98] Olczak, A.A., Wang, G., Maier, R.J., Up-expression of NapA and other oxidative stress proteins is a compensatory response to loss of major Helicobacter pylori stress resistance factors. Free Radic. Res. 39 (2005), 1173–1182.
99. [99] Wang, G., Maier, R.J., An NADPH quinone reductase of Helicobacter pylori plays an important role in oxidative stress resistance and host colonization. Infect. Immun. 72 (2004), 1391–1396.
100. [100] Siegel, D., Gustafson, D.L., Dehn, D.L., Han, J.Y., Boonchoong, P., Berliner, L.J., Ross, D., NAD(P)H: quinone oxidoreductase 1: role as a superoxide scavenger. Mol. Pharmacol. 65 (2004), 1238–1247.
101. [101] Kang, J.M., Iovine, N.M., Blaser, M.J., A paradigm for direct stress-induced mutation in prokaryotes. FASEB J. 20 (2006), 2476–2485.
102. [102] Linz, B., Windsor, H.M., McGraw, J.J., Hansen, L.M., Gajewski, J.P., Tomsho, L.P., Hake, C.M., Solnick, J.V., Schuster, S.C., Marshall, B.J., A mutation burst during the acute phase of Helicobacter pylori infection in humans and rhesus macaques. Nat. Commun., 5, 2014, 4165.
103. [103] Tomb, J.F., White, O., Kerlavage, A.R., Clayton, R.A., Sutton, G.G., Fleischmann, R.D., Ketchum, K.A., Klenk, H.P., Gill, S., Dougherty, B.A., Nelson, K., Quackenbush, J., Zhou, L., Kirkness, E.F., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H.G., Glodek, A., McKenney, K., Fitzegerald, L.M., Lee, N., Adams, M.D., Hickey, E.K., Berg, D.E., Gocayne, J.D., Utterback, T.R., Peterson, J.D., Kelley, J.M., Cotton, M.D., Weidman, J.M., Fujii, C., Bowman, C., Watthey, L., Wallin, E., Hayes, W.S., Borodovsky, M., Karp, P.D., Smith, H.O., Fraser, C.M., Venter, J.C., The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 (1997), 539–547.
104. [104] Alm, R.A., Trust, T.J., Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes. J. Mol. Med. 77 (1999), 834–846.
105. [105] O'Rourke, E.J., Chevalier, C., Pinto, A.V., Thiberge, J.M., Ielpi, L., Labigne, A., Radicella, J.P., Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonization. Proc. Natl. Acad. Sci. USA 100 (2003), 2789–2794.
106. [106] Laval, J., Jurado, J., Saparbaev, M., Sidorkina, O., Antimutagenic role of base-excision repair enzymes upon free radical-induced DNA damage. Mutat. Res. 402 (1998), 93–102.
107. [107] Wang, G., Alamuri, P., Humayun, M.Z., Taylor, D.E., Maier, R.J., The Helicobacter pylori MutS protein confers protection from oxidative DNA damage. Mol. Microbiol. 58 (2005), 166–176.
108. [108] Garcia-Ortiz, M.V., Marsin, S., Arana, M.E., Gasparutto, D., Guerois, R., Kunkel, T.A., Radicella, J.P., Unexpected role for Helicobacter pylori DNA polymerase I as a source of genetic variability. PLoS Genet, 7, 2011, e1002152.
109. [109] Finkel, T., Signal transduction by reactive oxygen species. J. Cell Biol. 194 (2011), 7–15.
110. [110] Tsugawa, H., Suzuki, H., Saya, H., Hatakeyama, M., Hirayama, T., Hirata, K., Nagano, O., Matsuzaki, J., Hibi, T., Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 12 (2012), 764–777.
111. [111] H.K. Ngo, H.G. Lee, J.Y. Piao, X. Zhong, H.N. Lee, H.J. Han, W. Kim, D.H. Kim, Y.N. Cha, H.K. Na, Y.J. Surh, Helicobacter pylori induces Snail expression through ROS-mediated activation of Erk and inactivation of GSK-3beta in human gastric cancer cells, Mol. Carcinog., 2016.
112. [112] J.Y. Piao, H.G. Lee, S.J. Kim, D.H. Kim, H.J. Han, H.K. Ngo, S.A. Park, J.H. Woo, J.S. Lee, H.K. Na, Y.N. Cha, Y.J. Surh, Helicobacter pylori activates IL-6-STAT3 signaling in human gastric cancer cells: Potential roles for reactive oxygen species, Helicobacter, 2016.
113. [113] Byun, E., Lim, J.W., Kim, J.M., Kim, H., alpha-Lipoic acid inhibits Helicobacter pylori-induced oncogene expression and hyperproliferation by suppressing the activation of NADPH oxidase in gastric epithelial cells. Mediat. Inflamm., 2014, 2014, 380830.
114. [114] Kang, M.J., Song, E.J., Kim, B.Y., Kim, D.J., Park, J.H., Helicobacter pylori induces vascular endothelial growth factor production in gastric epithelial cells through hypoxia-inducible factor-1alpha-dependent pathway. Helicobacter 19 (2014), 476–483.
115. [115] Semper, R.P., Mejias-Luque, R., Gross, C., Anderl, F., Muller, A., Vieth, M., Busch, D.H., Prazeres da Costa, C., Ruland, J., Gross, O., Gerhard, M., Helicobacter pylori-induced IL-1beta secretion in innate immune cells is regulated by the NLRP3 inflammasome and requires the cag pathogenicity island. J. Immunol. 193 (2014), 3566–3576.
116. [116] Li, X., Liu, S., Luo, J., Liu, A., Tang, S., Liu, S., Yu, M., Zhang, Y., Helicobacter pylori induces IL-1beta and IL-18 production in human monocytic cell line through activation of NLRP3 inflammasome via ROS signaling pathway. Pathog. Dis., 73, 2015.
117. [117] Keenan, J.I., Peterson, R.A. 2nd, Hampton, M.B., NADPH oxidase involvement in the pathology of Helicobacter pylori infection. Free Radic. Biol. Med. 38 (2005), 1188–1196.
118. [118] Blanchard, T.G., Yu, F., Hsieh, C.L., Redline, R.W., Severe inflammation and reduced bacteria load in murine Helicobacter infection caused by lack of phagocyte oxidase activity. J. Infect. Dis. 187 (2003), 1609–1615.
119. [119] Baik, S.C., Youn, H.S., Chung, M.H., Lee, W.K., Cho, M.J., Ko, G.H., Park, C.K., Kasai, H., Rhee, K.H., Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 56 (1996), 1279–1282.
120. [120] Farinati, F., Cardin, R., Degan, P., Rugge, M., Mario, F.D., Bonvicini, P., Naccarato, R., Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 42 (1998), 351–356.
121. [121] Papa, A., Danese, S., Sgambato, A., Ardito, R., Zannoni, G., Rinelli, A., Vecchio, F.M., Gentiloni-Silveri, N., Cittadini, A., Gasbarrini, G., Gasbarrini, A., Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosa. Scand. J. Gastroenterol. 37 (2002), 409–413.
122. [122] de Sablet, T., Piazuelo, M.B., Shaffer, C.L., Schneider, B.G., Asim, M., Chaturvedi, R., Bravo, L.E., Sicinschi, L.A., Delgado, A.G., Mera, R.M., Israel, D.A., Romero-Gallo, J., Peek, R.M. Jr., Cover, T.L., Correa, P., Wilson, K.T., Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 60 (2011), 1189–1195.
123. [123] Ding, S.Z., Minohara, Y., Fan, X.J., Wang, J., Reyes, V.E., Patel, J., Dirden-Kramer, B., Boldogh, I., Ernst, P.B., Crowe, S.E., Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect. Immun. 75 (2007), 4030–4039.
124. [124] Calvino-Fernandez, M., Benito-Martinez, S., Parra-Cid, T., Oxidative stress by Helicobacter pylori causes apoptosis through mitochondrial pathway in gastric epithelial cells. Apoptosis 13 (2008), 1267–1280.
125. [125] Hayakawa, Y., Hirata, Y., Kinoshita, H., Sakitani, K., Nakagawa, H., Nakata, W., Takahashi, R., Sakamoto, K., Maeda, S., Koike, K., Differential roles of ASK1 and TAK1 in Helicobacter pylori-induced cellular responses. Infect. Immun. 81 (2013), 4551–4560.
126. [126] Chaturvedi, R., Asim, M., Piazuelo, M.B., Yan, F., Barry, D.P., Sierra, J.C., Delgado, A.G., Hill, S., Casero, R.A. Jr., Bravo, L.E., Dominguez, R.L., Correa, P., Polk, D.B., Washington, M.K., Rose, K.L., Schey, K.L., Morgan, D.R., Peek, R.M. Jr., Wilson, K.T., Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. Gastroenterology 146 (2014), 1739–1751.
127. 2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid. Redox Signal. 7 (2005), 1014–1020.
128. [128] Wang, Y.C., Chen, C.L., Sheu, B.S., Yang, Y.J., Tseng, P.C., Hsieh, C.Y., Lin, C.F., Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-gamma signaling. J. Immunol. 193 (2014), 4149–4158.
129. 2. J. Biol. Chem. 273 (1998), 32554–32560.
130. [130] Meng, T.C., Fukada, T., Tonks, N.K., Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell. 9 (2002), 387–399.
131. [131] Kodaman, N., Pazos, A., Schneider, B.G., Piazuelo, M.B., Mera, R., Sobota, R.S., Sicinschi, L.A., Shaffer, C.L., Romero-Gallo, J., de Sablet, T., Harder, R.H., Bravo, L.E., Peek, R.M. Jr., Wilson, K.T., Cover, T.L., Williams, S.M., Correa, P., Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc. Natl. Acad. Sci. USA 111 (2014), 1455–1460.